Microtubule disruption and tumor suppression by mitogen-activated protein kinase phosphatase 4

Yuangang Liu, James Lagowski, Aaron Sundholm, Alexandra Sundberg, Molly Kulesz-Martin

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The extracellular signal-regulated kinase (Erk) is one of the downstream effectors of the Ras pathway whose activation is essential for the proliferation and survival of cancer cells. Erk activation is negatively regulated by mitogen-activated protein kinase (MAPK) phosphatases (MKP), which are generally up-regulated by Erk activation, thus forming a feedback loop for regulation of Erk activity. In searching for early alterations in the Ras pathway in epidermal carcinogenesis, we identified MKP4, a cytosolic MKP with specificity to not only Erk, but also, to a lesser extent, c-jun-NH2-kinase and p38. MKP4 is down-regulated at initiation and lost at malignant conversion in a clonal model of epidermal carcinogenesis that lacks Ras mutation. The loss of MKP4 was associated with squamous cell carcinoma (SCC) but not benign papilloma clonal lineages and with independently induced SCC relative to benign tumors in mouse skin. Reconstitution of MKP4 expression in malignant tumor cells leads to cell death and tumor suppression. Unlike Erk inhibition that blocks cell cycle entry, MKP4 reconstitution resulted in G2-M associated cell death and microtubule disruption. Thus, microtubule disruption by MKP4 provides a novel mechanism for tumor suppression by a cytosolic MKP and implies a novel therapeutic strategy through combined MAPK inhibitions that mimic the function of MKP4.

Original languageEnglish (US)
Pages (from-to)10711-10719
Number of pages9
JournalCancer Research
Volume67
Issue number22
DOIs
StatePublished - Nov 15 2007

Fingerprint

Mitogen-Activated Protein Kinase Phosphatases
Extracellular Signal-Regulated MAP Kinases
Microtubules
Neoplasms
Squamous Cell Carcinoma
Carcinogenesis
Cell Death
Papilloma
Mitogen-Activated Protein Kinases
rat Mapk4 protein
protein phosphatase 4
Cell Survival
Cell Cycle
Phosphotransferases
Skin
Mutation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Microtubule disruption and tumor suppression by mitogen-activated protein kinase phosphatase 4. / Liu, Yuangang; Lagowski, James; Sundholm, Aaron; Sundberg, Alexandra; Kulesz-Martin, Molly.

In: Cancer Research, Vol. 67, No. 22, 15.11.2007, p. 10711-10719.

Research output: Contribution to journalArticle

Liu, Yuangang ; Lagowski, James ; Sundholm, Aaron ; Sundberg, Alexandra ; Kulesz-Martin, Molly. / Microtubule disruption and tumor suppression by mitogen-activated protein kinase phosphatase 4. In: Cancer Research. 2007 ; Vol. 67, No. 22. pp. 10711-10719.
@article{ecfd753d045a45558b7a85d07578ede3,
title = "Microtubule disruption and tumor suppression by mitogen-activated protein kinase phosphatase 4",
abstract = "The extracellular signal-regulated kinase (Erk) is one of the downstream effectors of the Ras pathway whose activation is essential for the proliferation and survival of cancer cells. Erk activation is negatively regulated by mitogen-activated protein kinase (MAPK) phosphatases (MKP), which are generally up-regulated by Erk activation, thus forming a feedback loop for regulation of Erk activity. In searching for early alterations in the Ras pathway in epidermal carcinogenesis, we identified MKP4, a cytosolic MKP with specificity to not only Erk, but also, to a lesser extent, c-jun-NH2-kinase and p38. MKP4 is down-regulated at initiation and lost at malignant conversion in a clonal model of epidermal carcinogenesis that lacks Ras mutation. The loss of MKP4 was associated with squamous cell carcinoma (SCC) but not benign papilloma clonal lineages and with independently induced SCC relative to benign tumors in mouse skin. Reconstitution of MKP4 expression in malignant tumor cells leads to cell death and tumor suppression. Unlike Erk inhibition that blocks cell cycle entry, MKP4 reconstitution resulted in G2-M associated cell death and microtubule disruption. Thus, microtubule disruption by MKP4 provides a novel mechanism for tumor suppression by a cytosolic MKP and implies a novel therapeutic strategy through combined MAPK inhibitions that mimic the function of MKP4.",
author = "Yuangang Liu and James Lagowski and Aaron Sundholm and Alexandra Sundberg and Molly Kulesz-Martin",
year = "2007",
month = "11",
day = "15",
doi = "10.1158/0008-5472.CAN-07-1968",
language = "English (US)",
volume = "67",
pages = "10711--10719",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "22",

}

TY - JOUR

T1 - Microtubule disruption and tumor suppression by mitogen-activated protein kinase phosphatase 4

AU - Liu, Yuangang

AU - Lagowski, James

AU - Sundholm, Aaron

AU - Sundberg, Alexandra

AU - Kulesz-Martin, Molly

PY - 2007/11/15

Y1 - 2007/11/15

N2 - The extracellular signal-regulated kinase (Erk) is one of the downstream effectors of the Ras pathway whose activation is essential for the proliferation and survival of cancer cells. Erk activation is negatively regulated by mitogen-activated protein kinase (MAPK) phosphatases (MKP), which are generally up-regulated by Erk activation, thus forming a feedback loop for regulation of Erk activity. In searching for early alterations in the Ras pathway in epidermal carcinogenesis, we identified MKP4, a cytosolic MKP with specificity to not only Erk, but also, to a lesser extent, c-jun-NH2-kinase and p38. MKP4 is down-regulated at initiation and lost at malignant conversion in a clonal model of epidermal carcinogenesis that lacks Ras mutation. The loss of MKP4 was associated with squamous cell carcinoma (SCC) but not benign papilloma clonal lineages and with independently induced SCC relative to benign tumors in mouse skin. Reconstitution of MKP4 expression in malignant tumor cells leads to cell death and tumor suppression. Unlike Erk inhibition that blocks cell cycle entry, MKP4 reconstitution resulted in G2-M associated cell death and microtubule disruption. Thus, microtubule disruption by MKP4 provides a novel mechanism for tumor suppression by a cytosolic MKP and implies a novel therapeutic strategy through combined MAPK inhibitions that mimic the function of MKP4.

AB - The extracellular signal-regulated kinase (Erk) is one of the downstream effectors of the Ras pathway whose activation is essential for the proliferation and survival of cancer cells. Erk activation is negatively regulated by mitogen-activated protein kinase (MAPK) phosphatases (MKP), which are generally up-regulated by Erk activation, thus forming a feedback loop for regulation of Erk activity. In searching for early alterations in the Ras pathway in epidermal carcinogenesis, we identified MKP4, a cytosolic MKP with specificity to not only Erk, but also, to a lesser extent, c-jun-NH2-kinase and p38. MKP4 is down-regulated at initiation and lost at malignant conversion in a clonal model of epidermal carcinogenesis that lacks Ras mutation. The loss of MKP4 was associated with squamous cell carcinoma (SCC) but not benign papilloma clonal lineages and with independently induced SCC relative to benign tumors in mouse skin. Reconstitution of MKP4 expression in malignant tumor cells leads to cell death and tumor suppression. Unlike Erk inhibition that blocks cell cycle entry, MKP4 reconstitution resulted in G2-M associated cell death and microtubule disruption. Thus, microtubule disruption by MKP4 provides a novel mechanism for tumor suppression by a cytosolic MKP and implies a novel therapeutic strategy through combined MAPK inhibitions that mimic the function of MKP4.

UR - http://www.scopus.com/inward/record.url?scp=36349030782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36349030782&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-07-1968

DO - 10.1158/0008-5472.CAN-07-1968

M3 - Article

VL - 67

SP - 10711

EP - 10719

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 22

ER -